TRCT
THRD

Tower Research Capital (TRC)’s Third Harmonic Bio THRD Stock Holding History

Tower Research Capital (TRC)’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,907
Closed -$21.2K – 5632
2025
Q2 		$21.2K Sell
3,907
-34
-0.9% -$170 ﹤0.01% 3644
2025
Q1 		$13.7K Sell
3,941
-1,008
-20% -$4.89K ﹤0.01% 3338
2024
Q4 		$50.9K Buy
4,949
+4,254
+612% +$53K ﹤0.01% 2539
2024
Q3 		$9.42K Sell
695
-2,817
-80% -$34.9K ﹤0.01% 3869
2024
Q2 		$45.7K Buy
3,512
+3,162
+903% +$39.1K ﹤0.01% 3179
2024
Q1 		$3.3K Sell
350
-1,603
-82% -$15.6K ﹤0.01% 4886
2023
Q4 		$21.4K Sell
1,953
-187
-9% -$1.48K ﹤0.01% 3603
2023
Q3 		$13.7K Sell
2,140
-3,472
-62% -$21.2K ﹤0.01% 3763
2023
Q2 		$27K Buy
5,612
+3,186
+131% +$15.2K ﹤0.01% 3122
2023
Q1 		$10K Buy
2,426
+760
+46% +$3.23K ﹤0.01% 4408
2022
Q4 		$7K Buy
+1,666
New +$27.9K ﹤0.01% 4622

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Tower Research Capital (TRC)'s THRD Position: Q3 2025 in Review

Tower Research Capital (TRC) sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 3,907 shares — an estimated $21.2K sold.

Tower Research Capital (TRC) first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $50.9K in Q4 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Tower Research Capital (TRC) reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,907 Third Harmonic Bio shares in Q3 2025, an estimated $21.2K.
  • Tower Research Capital (TRC) first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Third Harmonic Bio position peaked at $50.9K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.